Higher FGF23 levels, even in individuals without renal insufficiency, correspond to an increased risk of cardiovascular mortality in the normal population (10), and cardiovascular risk factors including vascular dysfunction, atherosclerosis, and left ventricular hypertrophy (11-13). This evidence concerns the gene FGF23 and atherosclerosis.